-
Je něco špatně v tomto záznamu ?
Intratumoral Distribution and pH-Dependent Drug Release of High Molecular Weight HPMA Copolymer Drug Conjugates Strongly Depend on Specific Tumor Substructure and Microenvironment
AK. Noack, H. Lucas, P. Chytil, T. Etrych, K. Mäder, T. Mueller
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
project 19-01427S
Grantová Agentura České Republiky
MA 1648/8-1
Deutsche Forschungsgemeinschaft
Free Medical Journals od 2000
Freely Accessible Science Journals od 2000
PubMed Central od 2007
Europe PubMed Central od 2007
ProQuest Central od 2000-03-01
Open Access Digital Library od 2000-01-01
Open Access Digital Library od 2007-01-01
Health & Medicine (ProQuest) od 2000-03-01
ROAD: Directory of Open Access Scholarly Resources od 2000
Odkazy
PubMed
32825790
DOI
10.3390/ijms21176029
Knihovny.cz E-zdroje
- MeSH
- antitumorózní látky aplikace a dávkování chemie farmakokinetika MeSH
- buňky HT-29 MeSH
- doxorubicin aplikace a dávkování chemie farmakokinetika MeSH
- fluorescenční barviva chemie MeSH
- karbocyaniny chemie MeSH
- koncentrace vodíkových iontů MeSH
- lidé MeSH
- methakryláty chemie MeSH
- molekulová hmotnost MeSH
- myši nahé MeSH
- nádorové buněčné linie MeSH
- nádorové mikroprostředí MeSH
- nosiče léků aplikace a dávkování chemie farmakokinetika MeSH
- systémy cílené aplikace léků MeSH
- tkáňová distribuce MeSH
- uvolňování léčiv MeSH
- xenogenní modely - testy antitumorózní aktivity MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Stimulus-sensitive polymer drug conjugates based on high molecular weight N-(2-hydroxypropyl) methacrylamide (HPMA) copolymers carrying doxorubicin via a pH-dependent cleavable bond (pHPMA-Dox) were previously shown to be able to overcome multi-drug resistance. Nevertheless, a tumor type dependent differential response was observed. Although an improved and more selective tumor accumulation of pHPMA-Dox is generally achieved due to the enhanced permeability and retention (EPR) effect, little is known about the fate of these conjugates upon entering the tumor tissue, which could explain the different responses. In this study, we compared in vitro and in vivo accumulation and Dox-activation of pHPMA-Dox in three cancer cell line models (1411HP, A2780cis, HT29) and derived xenograft tumors using a near-infrared fluorescence-labeled pHPMA-Dox conjugate. Firstly, cytotoxicity assays using different pH conditions proved a stepwise, pH-dependent increase in cytotoxic activity and revealed comparable sensitivity among the cell lines. Using multispectral fluorescence microscopy, we were able to track the distribution of drug and polymeric carrier simultaneously on cellular and histological levels. Microscopic analyses of cell monolayers confirmed the assumed mechanism of cell internalization of the whole conjugate followed by intracellular cleavage and nuclear accumulation of Dox in all three cell lines. In contrast, intratumoral distribution and drug release in xenograft tumors were completely different and were associated with different tissue substructures and microenvironments analyzed by Azan- and Hypoxisense®-staining. In 1411HP tumors, large vessels and less hypoxic/acidic microenvironments were associated with a pattern resulting from consistent tissue distribution and cellular uptake as whole conjugate followed by intracellular drug release. In A2780cis tumors, an inconsistent pattern of distribution partly resulting from premature drug release was associated with a more hypoxic/acidic microenvironment, compacted tumor tissue with compressed vessels and specific pre-damaged tissue structures. A completely different distribution pattern was observed in HT29 tumors, resulting from high accumulation of polymer in abundant fibrotic structures, with small embedded vessels featuring this tumor type together with pronounced premature drug release due to the strongly hypoxic/acidic microenvironment. In conclusion, the pattern of intratumoral distribution and drug release strongly depends on the tumor substructure and microenvironment and may result in different degrees of therapeutic efficacy. This reflects the pronounced heterogeneity observed in the clinical application of nanomedicines and can be exploited for the future design of such conjugates.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21020247
- 003
- CZ-PrNML
- 005
- 20210830101851.0
- 007
- ta
- 008
- 210728s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms21176029 $2 doi
- 035 __
- $a (PubMed)32825790
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Noack, Anne-Kathrin $u Institute of Pharmacy, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany
- 245 10
- $a Intratumoral Distribution and pH-Dependent Drug Release of High Molecular Weight HPMA Copolymer Drug Conjugates Strongly Depend on Specific Tumor Substructure and Microenvironment / $c AK. Noack, H. Lucas, P. Chytil, T. Etrych, K. Mäder, T. Mueller
- 520 9_
- $a Stimulus-sensitive polymer drug conjugates based on high molecular weight N-(2-hydroxypropyl) methacrylamide (HPMA) copolymers carrying doxorubicin via a pH-dependent cleavable bond (pHPMA-Dox) were previously shown to be able to overcome multi-drug resistance. Nevertheless, a tumor type dependent differential response was observed. Although an improved and more selective tumor accumulation of pHPMA-Dox is generally achieved due to the enhanced permeability and retention (EPR) effect, little is known about the fate of these conjugates upon entering the tumor tissue, which could explain the different responses. In this study, we compared in vitro and in vivo accumulation and Dox-activation of pHPMA-Dox in three cancer cell line models (1411HP, A2780cis, HT29) and derived xenograft tumors using a near-infrared fluorescence-labeled pHPMA-Dox conjugate. Firstly, cytotoxicity assays using different pH conditions proved a stepwise, pH-dependent increase in cytotoxic activity and revealed comparable sensitivity among the cell lines. Using multispectral fluorescence microscopy, we were able to track the distribution of drug and polymeric carrier simultaneously on cellular and histological levels. Microscopic analyses of cell monolayers confirmed the assumed mechanism of cell internalization of the whole conjugate followed by intracellular cleavage and nuclear accumulation of Dox in all three cell lines. In contrast, intratumoral distribution and drug release in xenograft tumors were completely different and were associated with different tissue substructures and microenvironments analyzed by Azan- and Hypoxisense®-staining. In 1411HP tumors, large vessels and less hypoxic/acidic microenvironments were associated with a pattern resulting from consistent tissue distribution and cellular uptake as whole conjugate followed by intracellular drug release. In A2780cis tumors, an inconsistent pattern of distribution partly resulting from premature drug release was associated with a more hypoxic/acidic microenvironment, compacted tumor tissue with compressed vessels and specific pre-damaged tissue structures. A completely different distribution pattern was observed in HT29 tumors, resulting from high accumulation of polymer in abundant fibrotic structures, with small embedded vessels featuring this tumor type together with pronounced premature drug release due to the strongly hypoxic/acidic microenvironment. In conclusion, the pattern of intratumoral distribution and drug release strongly depends on the tumor substructure and microenvironment and may result in different degrees of therapeutic efficacy. This reflects the pronounced heterogeneity observed in the clinical application of nanomedicines and can be exploited for the future design of such conjugates.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antitumorózní látky $x aplikace a dávkování $x chemie $x farmakokinetika $7 D000970
- 650 _2
- $a karbocyaniny $x chemie $7 D002232
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a doxorubicin $x aplikace a dávkování $x chemie $x farmakokinetika $7 D004317
- 650 _2
- $a nosiče léků $x aplikace a dávkování $x chemie $x farmakokinetika $7 D004337
- 650 _2
- $a systémy cílené aplikace léků $7 D016503
- 650 _2
- $a uvolňování léčiv $7 D065546
- 650 _2
- $a fluorescenční barviva $x chemie $7 D005456
- 650 _2
- $a buňky HT-29 $7 D019073
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a koncentrace vodíkových iontů $7 D006863
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a methakryláty $x chemie $7 D008689
- 650 _2
- $a myši nahé $7 D008819
- 650 _2
- $a molekulová hmotnost $7 D008970
- 650 _2
- $a tkáňová distribuce $7 D014018
- 650 _2
- $a nádorové mikroprostředí $7 D059016
- 650 _2
- $a xenogenní modely - testy antitumorózní aktivity $7 D023041
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Lucas, Henrike $u Institute of Pharmacy, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany
- 700 1_
- $a Chytil, Petr $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovský Sq. 2, 162 06 Prague 6, Czech Republic
- 700 1_
- $a Etrych, Tomáš $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovský Sq. 2, 162 06 Prague 6, Czech Republic
- 700 1_
- $a Mäder, Karsten $u Institute of Pharmacy, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany
- 700 1_
- $a Mueller, Thomas $u University Clinic for Internal Medicine IV, Hematology/Oncology, Medical Faculty of Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 21, č. 17 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32825790 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830101851 $b ABA008
- 999 __
- $a ok $b bmc $g 1690934 $s 1140693
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 21 $c 17 $e 20200821 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- GRA __
- $a project 19-01427S $p Grantová Agentura České Republiky
- GRA __
- $a MA 1648/8-1 $p Deutsche Forschungsgemeinschaft
- LZP __
- $a Pubmed-20210728